203 related articles for article (PubMed ID: 36078164)
21. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract][Full Text] [Related]
22. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
[TBL] [Abstract][Full Text] [Related]
23. p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.
Sin TK; Zhu JZ; Zhang G; Li YP
Cancer Res; 2019 Apr; 79(7):1331-1342. PubMed ID: 30705122
[TBL] [Abstract][Full Text] [Related]
24. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.
Wang Y; Sun X; Yang Q; Guo C
Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890
[TBL] [Abstract][Full Text] [Related]
25. Taurine Rescues Cancer-induced Atrophy in Human Skeletal Muscle Cells
Chen CH; Chen YC; Chang YC; Hung CH; Huang CY; Tsai CL; Sun CK; Lin HY
Anticancer Res; 2024 May; 44(5):1963-1971. PubMed ID: 38677769
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of C2C12 myotube atrophy by a novel HSP70 inducer, celastrol, via activation of Akt1 and ERK1/2 pathways.
Gwag T; Park K; Kim E; Son C; Park J; Nikawa T; Choi I
Arch Biochem Biophys; 2013 Sep; 537(1):21-30. PubMed ID: 23810294
[TBL] [Abstract][Full Text] [Related]
27. Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
Lee JH; Kim SW; Kim JH; Kim HJ; Um J; Jung DW; Williams DR
Cells; 2021 Apr; 10(5):. PubMed ID: 33925786
[TBL] [Abstract][Full Text] [Related]
28. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
29. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Markov SD; Gonzalez D; Mehla K
Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
[TBL] [Abstract][Full Text] [Related]
31. Stimulated myotube contractions regulate membrane-bound and soluble TLR4 to prevent LPS-induced signaling and myotube atrophy in skeletal muscle cells.
Ducharme JB; Fennel ZJ; McKenna ZJ; Nava RC; Deyhle MR
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C300-C313. PubMed ID: 37335026
[TBL] [Abstract][Full Text] [Related]
32. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
33. Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model.
Chen L; Chen Y; Wang M; Lai L; Zheng L; Lu H
Eur J Pharmacol; 2024 Apr; 969():176429. PubMed ID: 38423241
[TBL] [Abstract][Full Text] [Related]
34. Myeloma extracellular vesicle-derived RAGE increases inflammatory responses and myotube atrophy in multiple myeloma through activation of the TLR4/NF-κB p65 pathway.
Wu Y; Yao X; Shi X; Xu Z; Ren J; Shi M; Li M; Liu J; Du X
Apoptosis; 2024 Jun; 29(5-6):849-864. PubMed ID: 38117373
[TBL] [Abstract][Full Text] [Related]
35. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
36. Cancer Takes a Toll on Skeletal Muscle by Releasing Heat Shock Proteins-An Emerging Mechanism of Cancer-Induced Cachexia.
Sin TK; Zhang G; Zhang Z; Gao S; Li M; Li YP
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480237
[TBL] [Abstract][Full Text] [Related]
37. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.
Bhatnagar S; Mittal A; Gupta SK; Kumar A
J Cell Physiol; 2012 Mar; 227(3):1042-51. PubMed ID: 21567392
[TBL] [Abstract][Full Text] [Related]
38. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
39. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
[TBL] [Abstract][Full Text] [Related]
40. Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic kidney disease.
Zhang YY; Yang M; Bao JF; Gu LJ; Yu HL; Yuan WJ
BMC Nephrol; 2018 Feb; 19(1):45. PubMed ID: 29486729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
